Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Erratum: Whole-genome sequence-based analysis of thyroid function.

Nature communications

Taylor PN, Porcu E, Chew S, Campbell PJ, Traglia M, Brown SJ, Mullin BH, Shihab HA, Min J, Walter K, Memari Y, Huang J, Barnes MR, Beilby JP, Charoen P, Danecek P, Dudbridge F, Forgetta V, Greenwood C, Grundberg E, Johnson AD, Hui J, Lim EM, McCarthy S, Muddyman D, Panicker V, Perry JR, Bell JT, Yuan W, Relton C, Gaunt T, Schlessinger D, Abecasis G, Cucca F, Surdulescu GL, Woltersdorf W, Zeggini E, Zheng HF, Toniolo D, Dayan CM, Naitza S, Walsh JP, Spector T, Smith GD, Durbin R, Richards JB, Sanna S, Soranzo N, Timpson NJ, Wilson SG.
PMID: 25989729
Nat Commun. 2015 May 20;6:7172. doi: 10.1038/ncomms8172.

No abstract available.

Cite
Taylor PN, Porcu E, Chew S, et al. Erratum: Whole-genome sequence-based analysis of thyroid function. Nat Commun. 2015;6:7172doi: 10.1038/ncomms8172.
Taylor, P. N., Porcu, E., Chew, S., Campbell, P. J., Traglia, M., Brown, S. J., Mullin, B. H., Shihab, H. A., Min, J., Walter, K., Memari, Y., Huang, J., Barnes, M. R., Beilby, J. P., Charoen, P., Danecek, P., Dudbridge, F., Forgetta, V., Greenwood, C., Grundberg, E., Johnson, A. D., Hui, J., Lim, E. M., McCarthy, S., Muddyman, D., Panicker, V., Perry, J. R., Bell, J. T., Yuan, W., Relton, C., Gaunt, T., Schlessinger, D., Abecasis, G., Cucca, F., Surdulescu, G. L., Woltersdorf, W., Zeggini, E., Zheng, H. F., Toniolo, D., Dayan, C. M., Naitza, S., Walsh, J. P., Spector, T., Smith, G. D., Durbin, R., Richards, J. B., Sanna, S., Soranzo, N., Timpson, N. J., Wilson, S. G. (2015). Erratum: Whole-genome sequence-based analysis of thyroid function. Nature communications, 67172. https://doi.org/10.1038/ncomms8172
Taylor, Peter N, et al. "Erratum: Whole-genome sequence-based analysis of thyroid function." Nature communications vol. 6 (2015): 7172. doi: https://doi.org/10.1038/ncomms8172
Taylor PN, Porcu E, Chew S, Campbell PJ, Traglia M, Brown SJ, Mullin BH, Shihab HA, Min J, Walter K, Memari Y, Huang J, Barnes MR, Beilby JP, Charoen P, Danecek P, Dudbridge F, Forgetta V, Greenwood C, Grundberg E, Johnson AD, Hui J, Lim EM, McCarthy S, Muddyman D, Panicker V, Perry JR, Bell JT, Yuan W, Relton C, Gaunt T, Schlessinger D, Abecasis G, Cucca F, Surdulescu GL, Woltersdorf W, Zeggini E, Zheng HF, Toniolo D, Dayan CM, Naitza S, Walsh JP, Spector T, Smith GD, Durbin R, Richards JB, Sanna S, Soranzo N, Timpson NJ, Wilson SG. Erratum: Whole-genome sequence-based analysis of thyroid function. Nat Commun. 2015 May 20;6:7172. doi: 10.1038/ncomms8172. PMID: 25989729; PMCID: PMC4462835.
Copy Download .nbib Format: NLM
REPAIR OF VESICOVAGINAL FISTULA.

Annals of surgery

Mellish MH.
PMID: 17863529
Ann Surg. 1916 Apr;63(4):512. doi: 10.1097/00000658-191604000-00018.

No abstract available.

Cite
Mellish MH. REPAIR OF VESICOVAGINAL FISTULA. Ann Surg. 1916;63(4):512doi: 10.1097/00000658-191604000-00018.
Mellish, M. H. (1916). REPAIR OF VESICOVAGINAL FISTULA. Annals of surgery, 63(4), 512. https://doi.org/10.1097/00000658-191604000-00018
Mellish, M H. "REPAIR OF VESICOVAGINAL FISTULA." Annals of surgery vol. 63,4 (1916): 512. doi: https://doi.org/10.1097/00000658-191604000-00018
Mellish MH. REPAIR OF VESICOVAGINAL FISTULA. Ann Surg. 1916 Apr;63(4):512. doi: 10.1097/00000658-191604000-00018. PMID: 17863529; PMCID: PMC1406851.
Copy Download .nbib Format: NLM
The gut microbiome: what every gastroenterologist needs to know.

Frontline gastroenterology

Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH.
PMID: 33613943
Frontline Gastroenterol. 2020 Feb 04;12(2):118-127. doi: 10.1136/flgastro-2019-101376. eCollection 2021.

The mucosal surfaces of the body are characterised by complex, specialised microbial communities, often referred to as the

Cite
Mullish BH, Quraishi MN, Segal JP, et al. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol. 2020;12(2):118-127doi: 10.1136/flgastro-2019-101376.
Mullish, B. H., Quraishi, M. N., Segal, J. P., Ianiro, G., & Iqbal, T. H. (2021). The gut microbiome: what every gastroenterologist needs to know. Frontline gastroenterology, 12(2), 118-127. https://doi.org/10.1136/flgastro-2019-101376
Mullish, Benjamin H, et al. "The gut microbiome: what every gastroenterologist needs to know." Frontline gastroenterology vol. 12,2 (2021): 118-127. doi: https://doi.org/10.1136/flgastro-2019-101376
Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol. 2020 Feb 04;12(2):118-127. doi: 10.1136/flgastro-2019-101376. eCollection 2021. PMID: 33613943; PMCID: PMC7873547.
Copy Download .nbib Format: NLM
[No title available]

Expert opinion on therapeutic targets

Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC.
PMID: 34793686
Expert Opin Ther Targets. 2021 Dec 02;1-15. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02.

AREAS COVERED: We searched PubMed and Web of Science databases for articles identifying novel therapeutic targets or treatments for EXPERT OPINION: Considerable progress has been made in the development of new anti-CDI drug candidates. Nevertheless, a greater comprehension of...

Cite
Monaghan TM, Seekatz AM, Mullish BH, et al. . Expert Opin Ther Targets. 2021;1-15doi: 10.1080/14728222.2021.2008907.
Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C. C. E. R., Dawson, L. F., Ahmed, A., Kao, D., & Chan, W. C. (2021). . Expert opinion on therapeutic targets, 1-15. https://doi.org/10.1080/14728222.2021.2008907
Monaghan, Tanya M, et al. "." Expert opinion on therapeutic targets vol. (2021): 1-15. doi: https://doi.org/10.1080/14728222.2021.2008907
Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. . Expert Opin Ther Targets. 2021 Dec 02;1-15. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02. PMID: 34793686.
Copy Download .nbib Format: NLM
Impact of gastrointestinal surgery upon the gut microbiome: A systematic review.

Surgery

Tarazi M, Jamel S, Mullish BH, Markar SR, Hanna GB.
PMID: 34809971
Surgery. 2021 Nov 19; doi: 10.1016/j.surg.2021.10.014. Epub 2021 Nov 19.

BACKGROUND: There is evidence from preclinical models that the gut microbiome may impact outcomes from gastrointestinal surgery, and that surgery may alter the gut microbiome. However, the extent to which gastrointestinal surgery modulates the gut microbiome in clinical practice...

Cite
Tarazi M, Jamel S, Mullish BH, et al. Impact of gastrointestinal surgery upon the gut microbiome: A systematic review. Surgery. 2021;doi: 10.1016/j.surg.2021.10.014.
Tarazi, M., Jamel, S., Mullish, B. H., Markar, S. R., & Hanna, G. B. (2021). Impact of gastrointestinal surgery upon the gut microbiome: A systematic review. Surgery, . https://doi.org/10.1016/j.surg.2021.10.014
Tarazi, Munir, et al. "Impact of gastrointestinal surgery upon the gut microbiome: A systematic review." Surgery vol. (2021). doi: https://doi.org/10.1016/j.surg.2021.10.014
Tarazi M, Jamel S, Mullish BH, Markar SR, Hanna GB. Impact of gastrointestinal surgery upon the gut microbiome: A systematic review. Surgery. 2021 Nov 19; doi: 10.1016/j.surg.2021.10.014. Epub 2021 Nov 19. PMID: 34809971.
Copy Download .nbib Format: NLM
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections.

Frontline gastroenterology

Nathwani R, Kockerling D, Mullish BH, Cole A, Lemoine M, Antoniades CG, Thursz MR, Dhar A.
PMID: 34970431
Frontline Gastroenterol. 2021 Mar 11;13(1):86-88. doi: 10.1136/flgastro-2021-101818. eCollection 2022.

No abstract available.

Cite
Nathwani R, Kockerling D, Mullish BH, et al. Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. Frontline Gastroenterol. 2021;13(1):86-88doi: 10.1136/flgastro-2021-101818.
Nathwani, R., Kockerling, D., Mullish, B. H., Cole, A., Lemoine, M., Antoniades, C. G., Thursz, M. R., & Dhar, A. (2022). Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. Frontline gastroenterology, 13(1), 86-88. https://doi.org/10.1136/flgastro-2021-101818
Nathwani, Rooshi, et al. "Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections." Frontline gastroenterology vol. 13,1 (2022): 86-88. doi: https://doi.org/10.1136/flgastro-2021-101818
Nathwani R, Kockerling D, Mullish BH, Cole A, Lemoine M, Antoniades CG, Thursz MR, Dhar A. Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. Frontline Gastroenterol. 2021 Mar 11;13(1):86-88. doi: 10.1136/flgastro-2021-101818. eCollection 2022. PMID: 34970431; PMCID: PMC8666853.
Copy Download .nbib Format: NLM
Unilateral Sacral Fractures Demonstrate Slow Recovery of Patient Reported Outcomes Irrespective of Treatment.

Journal of orthopaedic trauma

Mullis BH, Agel J, Jones C, Lowe J, Vallier H, Teague D, Kempton L, Schmidt A, Friess D, Morshed S, Miller A, Leighton R, Tornetta P.
PMID: 34483321
J Orthop Trauma. 2021 Aug 31; doi: 10.1097/BOT.0000000000002260. Epub 2021 Aug 31.

OBJECTIVES: To report functional outcomes of unilateral sacral fractures treated both operatively and nonoperatively.DESIGN: Prospective, multicenter, observational.SETTING: 16 level 1 trauma centersPatients/participants: Skeletally mature patients with unilateral zone 1 or 2 sacral fractures categorized as: displaced nonoperative (DN), displaced...

Cite
Mullis BH, Agel J, Jones C, et al. Unilateral Sacral Fractures Demonstrate Slow Recovery of Patient Reported Outcomes Irrespective of Treatment. J Orthop Trauma. 2021;doi: 10.1097/BOT.0000000000002260.
Mullis, B. H., Agel, J., Jones, C., Lowe, J., Vallier, H., Teague, D., Kempton, L., Schmidt, A., Friess, D., Morshed, S., Miller, A., Leighton, R., & Tornetta, P. (2021). Unilateral Sacral Fractures Demonstrate Slow Recovery of Patient Reported Outcomes Irrespective of Treatment. Journal of orthopaedic trauma, . https://doi.org/10.1097/BOT.0000000000002260
Mullis, Brian H, et al. "Unilateral Sacral Fractures Demonstrate Slow Recovery of Patient Reported Outcomes Irrespective of Treatment." Journal of orthopaedic trauma vol. (2021). doi: https://doi.org/10.1097/BOT.0000000000002260
Mullis BH, Agel J, Jones C, Lowe J, Vallier H, Teague D, Kempton L, Schmidt A, Friess D, Morshed S, Miller A, Leighton R, Tornetta P. Unilateral Sacral Fractures Demonstrate Slow Recovery of Patient Reported Outcomes Irrespective of Treatment. J Orthop Trauma. 2021 Aug 31; doi: 10.1097/BOT.0000000000002260. Epub 2021 Aug 31. PMID: 34483321.
Copy Download .nbib Format: NLM
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?.

Therapeutic advances in gastroenterology

Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR.
PMID: 33281941
Therap Adv Gastroenterol. 2020 Nov 24;13:1756284820974914. doi: 10.1177/1756284820974914. eCollection 2020.

The novel coronavirus infection (COVID-19) caused by the SARS-CoV-2 virus has spread rapidly across the globe, culminating in major global morbidity and mortality. As such, there has been a rapid escalation in scientific and clinical activity aimed at increasing...

Cite
Segal JP, Mak JWY, Mullish BH, et al. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?. Therap Adv Gastroenterol. 2020;13:1756284820974914doi: 10.1177/1756284820974914.
Segal, J. P., Mak, J. W. Y., Mullish, B. H., Alexander, J. L., Ng, S. C., & Marchesi, J. R. (2020). The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?. Therapeutic advances in gastroenterology, 131756284820974914. https://doi.org/10.1177/1756284820974914
Segal, Jonathan P, et al. "The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?." Therapeutic advances in gastroenterology vol. 13 (2020): 1756284820974914. doi: https://doi.org/10.1177/1756284820974914
Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?. Therap Adv Gastroenterol. 2020 Nov 24;13:1756284820974914. doi: 10.1177/1756284820974914. eCollection 2020. PMID: 33281941; PMCID: PMC7692338.
Copy Download .nbib Format: NLM
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

Inflammatory bowel diseases

Allegretti JR, Kelly CR, Grinspan A, Mullish BH, Hurtado J, Carrellas M, Marcus J, Marchesi JR, McDonald JAK, Gerardin Y, Silverstein M, Pechlivanis A, Barker GF, Miguens Blanco J, Alexander JL, Gallagher KI, Pettee W, Phelps E, Nemes S, Sagi SV, Bohm M, Kassam Z, Fischer M.
PMID: 33155639
Inflamm Bowel Dis. 2021 Aug 19;27(9):1371-1378. doi: 10.1093/ibd/izaa283.

BACKGROUND: Recurrent Clostridioides difficile infection (CDI) in patients with inflammatory bowel disease (IBD) is a clinical challenge. Fecal microbiota transplantation (FMT) has emerged as a recurrent CDI therapy. Anecdotal concerns exist regarding worsening of IBD activity; however, prospective data...

Cite
Allegretti JR, Kelly CR, Grinspan A, et al. Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection. Inflamm Bowel Dis. 2021;27(9):1371-1378doi: 10.1093/ibd/izaa283.
Allegretti, J. R., Kelly, C. R., Grinspan, A., Mullish, B. H., Hurtado, J., Carrellas, M., Marcus, J., Marchesi, J. R., McDonald, J. A. K., Gerardin, Y., Silverstein, M., Pechlivanis, A., Barker, G. F., Miguens Blanco, J., Alexander, J. L., Gallagher, K. I., Pettee, W., Phelps, E., Nemes, S., Sagi, S. V., Bohm, M., Kassam, Z., & Fischer, M. (2021). Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection. Inflammatory bowel diseases, 27(9), 1371-1378. https://doi.org/10.1093/ibd/izaa283
Allegretti, Jessica R, et al. "Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection." Inflammatory bowel diseases vol. 27,9 (2021): 1371-1378. doi: https://doi.org/10.1093/ibd/izaa283
Allegretti JR, Kelly CR, Grinspan A, Mullish BH, Hurtado J, Carrellas M, Marcus J, Marchesi JR, McDonald JAK, Gerardin Y, Silverstein M, Pechlivanis A, Barker GF, Miguens Blanco J, Alexander JL, Gallagher KI, Pettee W, Phelps E, Nemes S, Sagi SV, Bohm M, Kassam Z, Fischer M. Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection. Inflamm Bowel Dis. 2021 Aug 19;27(9):1371-1378. doi: 10.1093/ibd/izaa283. PMID: 33155639; PMCID: PMC8376126.
Copy Download .nbib Format: NLM
[No title available]

Expert opinion on therapeutic targets

Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC.
PMID: 34793686
Expert Opin Ther Targets. 2021 Nov;25(11):949-963. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02.

AREAS COVERED: We searched PubMed and Web of Science databases for articles identifying novel therapeutic targets or treatments for EXPERT OPINION: Considerable progress has been made in the development of new anti-CDI drug candidates. Nevertheless, a greater comprehension of...

Cite
Monaghan TM, Seekatz AM, Mullish BH, et al. . Expert Opin Ther Targets. 2021;25(11):949-963doi: 10.1080/14728222.2021.2008907.
Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C. C. E. R., Dawson, L. F., Ahmed, A., Kao, D., & Chan, W. C. (2021). . Expert opinion on therapeutic targets, 25(11), 949-963. https://doi.org/10.1080/14728222.2021.2008907
Monaghan, Tanya M, et al. "." Expert opinion on therapeutic targets vol. 25,11 (2021): 949-963. doi: https://doi.org/10.1080/14728222.2021.2008907
Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. . Expert Opin Ther Targets. 2021 Nov;25(11):949-963. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02. PMID: 34793686.
Copy Download .nbib Format: NLM
Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

PLoS genetics

Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, Magi R, Saxena R, Laisk T, Urbanek M, Hayes MG, Thorleifsson G, Fernandez-Tajes J, Mahajan A, Mullin BH, Stuckey BGA, Spector TD, Wilson SG, Goodarzi MO, Davis L, Obermayer-Pietsch B, Uitterlinden AG, Anttila V, Neale BM, Jarvelin MR, Fauser B, Kowalska I, Visser JA, Andersen M, Ong K, Stener-Victorin E, Ehrmann D, Legro RS, Salumets A, McCarthy MI, Morin-Papunen L, Thorsteinsdottir U, Stefansson K, Styrkarsdottir U, Perry JRB, Dunaif A, Laven J, Franks S, Lindgren CM, Welt CK.
PMID: 31805045
PLoS Genet. 2019 Dec 05;15(12):e1008517. doi: 10.1371/journal.pgen.1008517. eCollection 2019 Dec.

[This corrects the article DOI: 10.1371/journal.pgen.1007813.].

Cite
Day F, Karaderi T, Jones MR, et al. Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2019;15(12):e1008517doi: 10.1371/journal.pgen.1008517.
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., Magi, R., Saxena, R., Laisk, T., Urbanek, M., Hayes, M. G., Thorleifsson, G., Fernandez-Tajes, J., Mahajan, A., Mullin, B. H., Stuckey, B. G. A., Spector, T. D., Wilson, S. G., Goodarzi, M. O., Davis, L., Obermayer-Pietsch, B., Uitterlinden, A. G., Anttila, V., Neale, B. M., Jarvelin, M. R., Fauser, B., Kowalska, I., Visser, J. A., Andersen, M., Ong, K., Stener-Victorin, E., Ehrmann, D., Legro, R. S., Salumets, A., McCarthy, M. I., Morin-Papunen, L., Thorsteinsdottir, U., Stefansson, K., Styrkarsdottir, U., Perry, J. R. B., Dunaif, A., Laven, J., Franks, S., Lindgren, C. M., & Welt, C. K. (2019). Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS genetics, 15(12), e1008517. https://doi.org/10.1371/journal.pgen.1008517
Day, Felix, et al. "Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria." PLoS genetics vol. 15,12 (2019): e1008517. doi: https://doi.org/10.1371/journal.pgen.1008517
Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, Magi R, Saxena R, Laisk T, Urbanek M, Hayes MG, Thorleifsson G, Fernandez-Tajes J, Mahajan A, Mullin BH, Stuckey BGA, Spector TD, Wilson SG, Goodarzi MO, Davis L, Obermayer-Pietsch B, Uitterlinden AG, Anttila V, Neale BM, Jarvelin MR, Fauser B, Kowalska I, Visser JA, Andersen M, Ong K, Stener-Victorin E, Ehrmann D, Legro RS, Salumets A, McCarthy MI, Morin-Papunen L, Thorsteinsdottir U, Stefansson K, Styrkarsdottir U, Perry JRB, Dunaif A, Laven J, Franks S, Lindgren CM, Welt CK. Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2019 Dec 05;15(12):e1008517. doi: 10.1371/journal.pgen.1008517. eCollection 2019 Dec. PMID: 31805045; PMCID: PMC6894746.
Copy Download .nbib Format: NLM
Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human.

Frontiers in genetics

Yuan J, Tickner J, Mullin BH, Zhao J, Zeng Z, Morahan G, Xu J.
PMID: 31001327
Front Genet. 2019 Apr 02;10:288. doi: 10.3389/fgene.2019.00288. eCollection 2019.

Osteoporosis is a complex condition with contributions from, and interactions between, multiple genetic loci and environmental factors. This review summarizes key advances in the application of genetic approaches for the identification of osteoporosis susceptibility genes. Genome-wide linkage analysis (GWLA)...

Cite
Yuan J, Tickner J, Mullin BH, et al. Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human. Front Genet. 2019;10:288doi: 10.3389/fgene.2019.00288.
Yuan, J., Tickner, J., Mullin, B. H., Zhao, J., Zeng, Z., Morahan, G., & Xu, J. (2019). Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human. Frontiers in genetics, 10288. https://doi.org/10.3389/fgene.2019.00288
Yuan, Jinbo, et al. "Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human." Frontiers in genetics vol. 10 (2019): 288. doi: https://doi.org/10.3389/fgene.2019.00288
Yuan J, Tickner J, Mullin BH, Zhao J, Zeng Z, Morahan G, Xu J. Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human. Front Genet. 2019 Apr 02;10:288. doi: 10.3389/fgene.2019.00288. eCollection 2019. PMID: 31001327; PMCID: PMC6455049.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries